Patents by Inventor Richard A. Carrano

Richard A. Carrano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen
    Publication number: 20030072759
    Abstract: Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
    Type: Application
    Filed: July 16, 2002
    Publication date: April 17, 2003
    Applicant: Centocor, Inc.
    Inventors: Hubert J.P. Schoemaker, Richard A. Carrano
  • Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen
    Patent number: 6444207
    Abstract: Disclosed is a method for treating a gastrointestinal tumor by administering a murine antibody which specifically binds an epitope of 17-1A antigen.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: September 3, 2002
    Assignee: Centocor, Inc.
    Inventors: Hubert J. P. Schoemaker, Richard A. Carrano
  • Compositions and methods for delivery of genetic material
    Patent number: 6197755
    Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a genetic vaccine facilitator and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produce a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: March 6, 2001
    Assignees: The Trustees of the University of Pennsylvania, Apollan, Inc.
    Inventors: Richard A. Carrano, Bin Wang, David B. Weiner
  • Compositions and methods for delivery of genetic material
    Patent number: 5962428
    Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a genetic vaccine facilitator and administering to the cells a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: October 5, 1999
    Assignees: Apollon, Inc., The Trustees Of The University of Pennsylvania
    Inventors: Richard A. Carrano, Bin Wang, David B. Weiner
  • Compositions and methods for delivery of genetic material
    Patent number: 5739118
    Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a genetic vaccine facilitator and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produce a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: April 14, 1998
    Assignees: Apollon, Inc., The Trustees of the University of Pennsylvania
    Inventors: Richard A. Carrano, Bin Wang, David B. Weiner